4 ms·
Depends on what competitors are charging, right? In this case it seems to indicate market failure.
by Luc 5y ago
Depends on what competitors are charging, right? In this case it seems to indicate market failure.
- ncallaway 5y agoAre competitors charging for the product, or is it covered under patent? I don't know the market, but it appears that it may be patented until 2030 (https://www.pharmacompass.com/patent-expiry-expiration/indomethacin https://www.pharmacompass.com/patent-expiry-expiration/indom...). That being said, drug patents are complicated, and there might be competitors for this drug.
- s1artibartfast 5y agoThe original drug was approved in 1965[1], and there are more than a hundred competitors[2], and the average price is somewhere around $2/day [3]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017814s044lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/01... https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=indomethacin https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=a... https://clincalc.com/DrugStats/Drugs/Indomethacin https://clincalc.com/DrugStats/Drugs/Indomethacin